Meticulous Research®, a leading global market research company, published a research report titled, ‘Europe In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, PoC) - Forecast to 2030.’
In vitro diagnostics (IVD) are tests performed on biological samples such as blood, saliva, and other tissues taken from the human body to detect a wide range of diseases. IVD tests are used to screen biological samples to monitor individuals’ health and prevent or diagnose diseases. These consist of various tests based on techniques such as enzyme-linked immunosorbent assay (ELISA), radioimmunoassay, polymerase chain reaction (PCR), isothermal nucleic acid amplification, and next-generation sequencing. These tests can be performed in laboratories, homes, and healthcare facilities.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5718
Key Players:
The key players operating in the Europe IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), Agilent Technologies Inc. (U.S.), and DiaSorin S.p.A. (Italy)
Europe IVD Market: Future Outlook
The Europe IVD market is segmented by Offering (Kits & Reagents, Systems, and Software & Services), Technology (Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Molecular Diagnostics, Point of Care (POC) Diagnostics, Whole Blood Glucose Monitoring, Microbiology, Hematology, Coagulation/Hemostasis, Urinalysis, and Other Technologies), Application (Infectious Diseases, Oncology, Diabetes, Cardiology, Nephrology, Autoimmune Disorders, and Other Applications), Diagnostic Approach (Lab Testing, OTC/Self-testing, and Point of Care Testing), and End User (Diagnostic Laboratories, Hospitals & Clinics, Home Healthcare, and Other End Users), and Countries. The study also evaluates industry competitors and analyzes their market share at the country level.
Have Any Query ? Speak To Analyst : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5718
Among all technologies studied in this report, in 2023, the molecular diagnostic segment is expected to account for the largest share of the Europe IVD market. The large market share of this segment is attributed to the rising prevalence of communicable and non-communicable diseases and the growth in the geriatric population. Moreover, the introduction of advancements in molecular diagnostic techniques, such as Nucleic Acid Amplification Testing (NAAT), is giving more access for high volume testing in less time and better specificity, increasing the adoption of molecular diagnostic techniques.
Request Sample Report : https://www.meticulousresearch.com/request-sample-report/cp_id=571
Among all applications studied in this report, in 2023, the infectious disease segment is expected to account for the largest share of the Europe IVD market. Infectious diseases are further categorized into respiratory infections (excluding influenza), hepatitis, HIV, HAIs, tropical diseases, influenza, sexually transmitted diseases (STDs), and other infectious diseases. The increasing prevalence of healthcare-associated infections (HAIs) and sexually transmitted diseases (STDs) is increasing the demand for IVD testing. According to the UK Health Security Agency (UKHSA), in 2022, 392,453 cases of sexually transmitted infections (STIs) were reported in the U.K., an increase of 24% than 2021.
Rising Awareness Regarding Early Disease Diagnosis is Driving the Market
Early diagnosis of infectious diseases leads to better treatment and future care. It helps healthcare professionals and patients make important medical decisions regarding care and support. There is a growing awareness about early disease diagnosis due to its advantages. Diagnosing a disease in its early stages can help patients save significantly on treatment costs. For instance, according to the WHO, studies conducted in some high-income countries have revealed that the treatment of cancer patients diagnosed early leads to cost savings by two to four times. Additionally, early diagnosis can be lifesaving for patients with critical diseases such as cancer.
Quick Buy @ https://www.meticulousresearch.com/Checkout/57334207
Laboratory examination is one of the most effective and popularly practiced testing techniques for disease diagnosis. Immunoassays, biochemical characterization, polymerase chain reaction, isothermal nucleic acid amplification, and next-generation sequencing are performed to identify a comprehensive range of chronic and infectious diseases. Organizations are undertaking initiatives to promote early diagnosis and prevent/eradicate mortalities associated with infectious diseases.
Scope of the Report:
Europe In Vitro Diagnostics Market, by Offering
• Kits & Reagents
• Instruments
• Software & Services
Europe In Vitro Diagnostics Market, by Technology
• Molecular Diagnostics
o Polymerase Chain Reaction (PCR)
o Hybridization
o Isothermal Nucleic Acid Amplification Technology
o DNA Sequencing & Next-generation Sequencing
o Microarrays
o Mass Spectrometry
o Other Molecular Diagnostic Technologies
(Note: Other Molecular Diagnostic Technologies majorly include electrophoresis, Ligase Chain Reaction (LCR), Northern Blot, and Southern Blot)
• Point of Care (PoC) Diagnostics
o Lateral Flow Assays/Rapid Tests
o POC Molecular Diagnostics
o Other PoC Products
(Note: Other PoC products include coagulation tests and blood glucose monitoring systems)
• Immunoassay/Immunochemistry
o Enzyme-linked Immunosorbent Assays (ELISA)
o Radioimmunoassays
o Western Blotting
o Enzyme-Linked Immunospot Assays
o Immunohistochemistry (IHC)
• Biochemistry/Clinical Chemistry
o Metabolic Panel
o Electrolyte Panel
o Liver Panel
o Lipid Profile
o Renal Profile
o Thyroid Function Panel
• Whole Blood Glucose Monitoring
• Microbiology
• Hematology
• Coagulation/Hemostasis
• Urinalysis
• Other IVD Technologies
(Note: Other IVD technologies comprise anatomical pathology, histochemistry, and loop-mediated amplification)

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- [email protected]
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research